How Investors Are Reacting To Haw Par (SGX:H02) Earnings And EPS Declines In First Half 2026

Simply Wall St.08-17

Haw Par Corporation Limited reported past half-year results for the period ended June 30, 2026, with sales of S$115.93 million and net income of S$107.87 million, both lower than a year earlier. The ...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2660000351?lang=en_US&edition=fundamental","thumbnail":"https://images.simplywall.st/asset/industry/6121000-choice2-main-header/1585186699299","is_english":true,"pubTime":"2026-08-17 11:28","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2660000351","market":"us","top_or_hot":-1,"title":"How Investors Are Reacting To Haw Par (SGX:H02) Earnings And EPS Declines In First Half 2026","media":"Simply Wall St.","content":"<div>\n<p>Haw Par Corporation Limited reported past half-year results for the period ended June 30, 2026, with sales of S$115.93 million and net income of S$107.87 million, both lower than a year earlier. The ...</p>\n\n<a href=\"https://simplywall.st/stocks/sg/pharmaceuticals-biotech/sgx-h02/haw-par-shares/news/how-investors-are-reacting-to-haw-par-sgxh02-earnings-and-ep\">Source Link</a>\n\n</div>\n","source":"simplywall_highlight","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>How Investors Are Reacting To Haw Par (SGX:H02) Earnings And EPS Declines In First Half 2026</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nHow Investors Are Reacting To Haw Par (SGX:H02) Earnings And EPS Declines In First Half 2026\n</h2>\n\n<h4 class=\"meta\">\n\n\n2026-08-17 11:28 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://simplywall.st/stocks/sg/pharmaceuticals-biotech/sgx-h02/haw-par-shares/news/how-investors-are-reacting-to-haw-par-sgxh02-earnings-and-ep><strong>Simply Wall St.</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Haw Par Corporation Limited reported past half-year results for the period ended June 30, 2026, with sales of S$115.93 million and net income of S$107.87 million, both lower than a year earlier. The ...</p>\n\n<a href=\"https://simplywall.st/stocks/sg/pharmaceuticals-biotech/sgx-h02/haw-par-shares/news/how-investors-are-reacting-to-haw-par-sgxh02-earnings-and-ep\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"H02.SI","symbol_name":"虎豹企业","start_time":0,"source_url":"https://simplywall.st/stocks/sg/pharmaceuticals-biotech/sgx-h02/haw-par-shares/news/how-investors-are-reacting-to-haw-par-sgxh02-earnings-and-ep","article_id":"2660000351","we_media_id":null,"thumbnails":["https://images.simplywall.st/asset/industry/6121000-choice2-main-header/1585186699299"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/sg/pharmaceuticals-biotech/sgx-h02/haw-par-shares/news/how-investors-are-reacting-to-haw-par-sgxh02-earnings-and-ep","rn_cache_url":null,"directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=2660000351","pubTimestamp":1786937281,"columns":[],"sourceInfo":{"source_id":"simplywall_highlight","name":"Simply Wall St."},"weMediaInfo":null,"summary":"Haw Par Corporation Limited reported past half-year results for the period ended June 30, 2026, with sales of S$115.93 million and net income of S$107.87 million, both lower than a year earlier.\nThe drop in basic earnings per share from S$0.651 to S$0.487 highlights weaker profitability from continuing operations over the half-year period.\nWe’ll now examine how this earnings decline, particularly the reduced basic earnings per share, shapes Haw Par’s investment narrative for investors.\nThe...","collect":0,"end_time":0,"defaultTopTitle":"simplywall.st","property":["earning"],"viewcount":null,"language":"en","relate_stocks":{"H02.SI":"虎豹企业","ISBC":"投资者银行"},"translate_title":"投资者对 Haw Par (SGX:H02) 2026 年上半年盈利和每股收益下降有何反应","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"ISBC":1.5,"H02.SI":1.5},"content_text":"Haw Par Corporation Limited reported past half-year results for the period ended June 30, 2026, with sales of S$115.93 million and net income of S$107.87 million, both lower than a year earlier. The drop in basic earnings per share from S$0.651 to S$0.487 highlights weaker profitability from continuing operations over the half-year period. We’ll now examine how this earnings decline, particularly the reduced basic earnings per share, shapes Haw Par’s investment narrative for investors. The future of work is here. Discover the 37 top robotics and automation stocks leading the charge in AI-driven automation and industrial transformation.AdvertisementWhat Is Haw Par's Investment Narrative?For someone considering Haw Par, the big picture still revolves around owning a conservatively run business that combines established healthcare brands with a sizeable investment portfolio and a consistent dividend record. The latest half-year result, with softer sales and a clear step down in basic EPS, puts more focus on whether recent profitability can support that story in the near term. Short term, the key catalysts investors were watching, such as earnings stability and the ability to keep funding dividends out of ongoing cash generation, now look less straightforward but not necessarily broken, especially given the share price has only eased modestly in recent weeks. Instead, this news mainly sharpens existing risks: slower profit growth, relatively low return on equity and a valuation that is not obviously cheap. However, one risk now feels more pressing than before: the pressure on Haw Par’s earnings resilience.\n\nHaw Par's share price has been on the slide but might be dropping deeper into value territory. Find out whether it's a bargain at this price.Exploring Other PerspectivesSGX:H02 1-Year Stock Price Chart Investors in the Simply Wall St Community currently span a wide fair value range for Haw Par, from about S$5.80 to S$20.60 across 2 separate views, underlining how differently its prospects are being modelled. Set against the recent earnings decline and questions over returns on equity discussed above, this spread of opinions invites you to weigh how much short term earnings pressure might matter for Haw Par’s longer term performance.Explore 2 other fair value estimates on Haw Par - why the stock might be worth as much as 33% more than the current price!Form Your Own VerdictDisagree with this assessment? Extraordinary investment returns rarely come from following the herd, so go with your instincts.A great starting point for your Haw Par research is our analysis highlighting 2 key rewards and 1 important warning sign that could impact your investment decision.Our free Haw Par research report provides a comprehensive fundamental analysis summarized in a single visual - the Snowflake - making it easy to evaluate Haw Par's overall financial health at a glance.Ready To Venture Into Other Investment Styles?Our top stock finds are flying under the radar-for now. Get in early:Invest in the nuclear renaissance through our list of 92 elite nuclear energy infrastructure plays powering the global AI revolution.Outshine the giants: these 17 early-stage AI stocks could fund your retirement.This technology could replace computers: discover 24 stocks that are working to make quantum computing a reality.  This article by Simply Wall St is general in nature. We provide commentary based on historical data\n    and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your\n    financial situation. We aim to bring you long-term focused analysis driven by fundamental data.\n    Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material.\n    Simply Wall St has no position in any stocks mentioned.Valuation is complex, but we're here to simplify it.Discover if Haw Par might be undervalued or overvalued with our detailed analysis, featuring fair value estimates, potential risks, dividends, insider trades, and its financial condition.Access Free AnalysisHave feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":false,"editions":null,"column":"","sentiment":"-1","news_tag":"dataReport","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.49.0","shortVersion":"4.49.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2660000351","isCrawlerRequest":true}